bioresorbable nasal implant

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

Representative image of a bioresorbable drug-eluting nasal scaffold used in chronic rhinosinusitis care, reflecting the latest innovations in ENT treatment compliance and intranasal drug delivery.

Can bioresorbable drug‑eluting scaffolds solve the compliance problem in chronic sinus care?

Can bioresorbable nasal implants like ARIS and PROPEL improve compliance in chronic sinus care? Explore how this growing tech is reshaping ENT drug delivery.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

September 8, 2025